Eisai to Present Latest Data on Lemborexant at The 36th Annual Sleep 2022 Meeting
TOKYO, Jun 3, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced a total of seven poster presentations including the latest data on its in-house discovered orexin receptor antagonist lemborexant (product name: DAYVIGO) will be given at the 36th annual meeting of the Associated Professional Sleep Societies (SLEEP 2022), to be held from... » read more
